Menu Back toOpening Plenary : Bio-venture / Mega-pharma Building Ecosystems In Asia

DIA Asia 2021-The Evolution Of Clinical Trials And Regulatory Science In A Post-Pandemic Digital World In Asia

The timing is as per Singapore Time Zone


Opening Plenary : Bio-venture / Mega-pharma Building Ecosystems In Asia

Session Chair(s)

Junko  Sato, PhD

Junko Sato, PhD

  • Director, Office of International Programs
  • Pharmaceuticals and Medical Devices Agency (PMDA), Japan
Jing Ping  Yeo, PhD

Jing Ping Yeo, PhD

  • Vice President- Asia Pacific head
  • Cytel International , Singapore
The growth potential of Asia pharmaceutical and life science industries is astounding over the past few years and this sector is poised for growth. Despite Asia being a collection of markets with very diverse sets of regulatory environments, demographics, economic impact and disease profiles, Asia eco-system is investing in its capabilities to advance patient centricity and expectations of healthcare and life science experience. The scientific and technological developments in cell and gene therapies, mRNA, digital analytics capabilities, patient centric delivery, smart health devices are changing the current business models and driving cross-sector economy. In this plenary, we will review how the bioventures, mega pharmas, small startups collaborate with governments and regulators to build an innovative and sustainable ecosystem, so as to support the transformation into a patient centric, valued focused research landscape.

Speaker(s)

Danny  Soon

Bio-venture / mega-pharma building ecosystems in Asia

Danny Soon

  • Chief Executive Officer Consortium for Clinical Research & Innovation Singapore
  • Executive Director Singapore Clinical Research Institute, Singapore
Danny  Soon

Panel Discussion

Danny Soon

  • Chief Executive Officer Consortium for Clinical Research & Innovation Singapore
  • Executive Director Singapore Clinical Research Institute, Singapore
Timothy  Low

Participating Panelist

Timothy Low

  • Head of Healthcare Investment
  • Pavilion Capital International Pte Ltd, Singapore
Celine   Ting

Participating Panelist

Celine Ting

  • Managing Director
  • Eisai (Singapore) Pte Ltd, Singapore

Contact us

Registration Questions?


Send Email
+91 9029098844